The analysts of Healthcare Intelligence Markets have thoroughly examined the Global High Throughput Screening Market and have anticipated that the market will grow at a CAGR of +7% during the forecast period.
High throughput screening is referred to a set of steps that is involved in the drug discovery procedure and assessment of large number of biological modulators as well as effectors against selected target. The experimental samples in this, are exposed to some relevant conditions under given circumstances to a simultaneous testing. High throughput screening encompasses of numerous steps such as target identification, reagent preparation, compound management, assay development, and high-throughput library screening. The main objective of evolving high throughput screening method is to fast-track drug discovery procedure by screening large number of multiple libraries such as combinatorial chemistry, genomics, protein, and peptide libraries at a rate that may surpass a few thousand compounds per day or week. High-throughput screening methods are also used to describe metabolic, pharmacokinetic, and toxicological data for new drugs and thus, ultimately reduces the cost of the drug expansion.
For Sample Copy of This report https://www.healthcareintelligencemarkets.com/request_sample.php?id=29069
The increase in the government funding and advancements in high throughput screening techniques are some of the major key factors that is driving the growth of this market tremendously.
The High Throughput Screening Market provides its segmentations by application such as drug discovery programs, chemical biology programs, biochemical screening, cell & organ-based screening. Along with this, it also provides an in-depth analysis of the prominent factors that influence the market which includes drivers, opportunities, trends and industry-specific challenges.
Some of the players operating in the high throughput screening market are Agilent Technologies, Inc., Danaher Corporation, Perkinelmer, Inc., Thermo Fisher Scientific Inc., Axxam S.P.A., Tecan Group Ltd., Bio-Rad Laboratories, Inc., Hamilton Company, Sigma-Aldrich Corporation (A Division of Merck Millipore), Aurora Biomed, Inc., among the others.
Agilent Technologies, Inc. is helping different companies with high throughput applications such as lead discovery and ADME. It also makes use of automation platforms and rapidfire/MS solutions.
All the technological advancements such as automation of liquid handling, growth of analytical tools to deal with massive quantities of data and creation of novel technological platforms are exponentially driving the growth of the market. But, due to the high cost of HTS techniques, the market is getting limited with its development. However, there is an upsurge in the competition among the pharma companies, which is increasing the demand of drug discovery and thus, is progressing the growth of the high throughput screening market.
Avail Discount on This report: https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=29069
o By Technology
o Cell Based Assays
Ø Fluorometric Imaging Plate Reader Assays
Ø Clinical Application (Cardiotoxicity Assays)
Ø In-Vitro Studies (Pharmacophores Identification in Drug Discovery)
o Reporter Based Assays
Ø Clinical Applications (Biological Systems Analysis)
Ø In-Vitro Studies (Cloning Tools for Live-Cell Work
o 3D-Cell Cultures
Ø Clinical Application (Regenerative Medicine)
Ø In-Vitro Medicine (Drug Discovery)
o Ultra High Throughput Screening
o By Application
o Drug Discovery Programs
o Chemical Biology Programs
o Biochemical Screening
o Cell & Organ-Based Screening
o By Product
o Consumables & Reagents,
• By End Users
o Pharmaceutical & Biotechnological Companies
o Academic & Government Research Institutes
o Contract Research Institutes
• By Region
o North America
o Asia Pacific
o Latin America